<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mutations in the gene for fibrillin-1 (FBN1) have been shown to cause <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, an <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">disorder of connective tissue</z:e> characterised by pleiotropic manifestations involving primarily the ocular, skeletal, and cardiovascular systems </plain></SENT>
<SENT sid="1" pm="."><plain>Fibrillin-1 is a major component of the 10-12 nm microfibrils, which are thought to play a role in tropoelastin deposition and elastic fibre formation in addition to possessing an anchoring function in some tissues </plain></SENT>
<SENT sid="2" pm="."><plain>Fibrillin-1 mutations have also been found in patients who do not fulfil clinical criteria for the diagnosis of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, but have related <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">disorders of connective tissue</z:e>, such as isolated <z:hpo ids='HP_0001083'>ectopia lentis</z:hpo>, familial <z:hpo ids='HP_0004942'>aortic aneurysm</z:hpo>, and Marfan-like <z:hpo ids='HP_0000924'>skeletal abnormalities</z:hpo>, so that <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> may be regarded as one of a range of type 1 fibrillinopathies </plain></SENT>
<SENT sid="3" pm="."><plain>There appear to be no particular hot spots since mutations are found throughout the entire fibrillin-1 gene </plain></SENT>
<SENT sid="4" pm="."><plain>However, a clustering of mutations associated with the most severe form of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, neonatal <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>, has been noted in a region encompassing exons 24 to 32 </plain></SENT>
<SENT sid="5" pm="."><plain>The gene for fibrillin-2 (FBN2) is highly homologous to FBN1, and mutations in FBN2 have been shown to cause a phenotypically related disorder termed congenital contractural <z:hpo ids='HP_0001166'>arachnodactyly</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Since mutations in the fibrillin genes are likely to affect the global function of the microfibrils, the term microfibrillopathy may be the most appropriate to designate the spectrum of disease associated with dysfunction of these molecules </plain></SENT>
<SENT sid="7" pm="."><plain>The understanding of the global and the molecular functions of the fibrillin containing microfibrils is still incomplete and, correspondingly, no comprehensive theory of the pathogenesis of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> has emerged to date </plain></SENT>
<SENT sid="8" pm="."><plain>Many, but not <z:hpo ids='HP_0000001'>all</z:hpo>, fibrillin-1 gene mutations are expected to exert a dominant negative effect, whereby mutant fibrillin monomers impair the global function of the microfibrils </plain></SENT>
<SENT sid="9" pm="."><plain>In this paper we review the molecular <z:mp ids='MP_0001532'>physiology</z:mp> and pathophysiology of <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> and related microfibrillopathies </plain></SENT>
</text></document>